U.S. Markets closed

New antibiotics desperately needed for rising tide of drug-resistant ‘superbugs’

Ron Leuty
New antibiotics desperately needed for rising tide of drug-resistant ‘superbugs’

Solving superbugs remains an open question in the world of biotech. So why aren’t Bay Area drug companies and investors interested?